Extension of Time to File SOU

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1581 (Rev 09/2005)

OMB No. 0651-0054 (Exp 12/31/2020)

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: CTX130 (see, http://uspto.report/TM/88296767/mark.png)
SERIAL NUMBER: 88296767

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: CRISPR Therapeutics AG, having an address of
      Aeschenvorstadt 36
      Basel, 4051
      Switzerland
      Email: XXXX
Proposed: CRISPR Therapeutics AG, having an address of
      Aeschenvorstadt 36
      Basel, 4051
      Switzerland
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 11/12/2019.

For International Class 005:
Current identification: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Tiffany D. Gehrke
      PRIMARY EMAIL FOR CORRESPONDENCE: docket@marshallip.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tgehrke@marshallip.com

Correspondence Information (proposed):
      Tiffany D. Gehrke
      PRIMARY EMAIL FOR CORRESPONDENCE: docket@marshallip.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tgehrke@marshallip.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Anders Kassow/      Date Signed: 11/11/2020
Signatory's Name: Anders Kassow
Signatory's Position: Executive Director, Intellectdual Property

RAM Sale Number: 88296767
RAM Accounting Date: 11/12/2020

Serial Number: 88296767
Internet Transmission Date: Wed Nov 11 12:08:42 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XXX-202011111208425
14122-88296767-750e61e4c6b3952a7631f3311
fd34a23acc165489d9e6e1334bc31f9525da6724
1-CC-08414377-20201102122011199182